Features

• Quick, reliable results for flu and COVID-19 test in only 10 minutes
• The QUICKVUE Influenza + SARS Tests can differentiate between SARS-CoV-2, influenza A and influenza B antigens directly from anterior nares swab specimen
• Simple workflow
• Two-color visual read result
• Actionable results available in as few as 10 minutes
• Outstanding clinical performance with over 99% of negative percent agreement (NPA) and over 85% of positive percent agreement (PPA)
• The QuickVue Influenza+SARS Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab samples from individuals with signs and symptoms of respiratory tract infection
• This test is for use by individuals aged 14 years or older testing themselves, or adults testing aged 2 years or older
• All negative results are presumptive and should be confirmed with an FDA-cleared molecular assay when determined to be appropriate by a healthcare provider
• Negative results do not rule out infection with influenza, SARS-CoV-2, or other pathogens
• Positive results do not rule out co-infection with other respiratory pathogens

Product Specifications